Skip to content

Comparing Urine and Cervical Swab Tests to Detect HPV Infection and Assess Cervical Cancer Risk in Women

HPV Detection in Urine and Cervical Swabs: A Comparative Analysis with Oncogenic Risk Assessment - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104600
Enrollment
216
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Poornisha J
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women who come for cervical screening in the reproductive age group and elderly (aged 21-65 years) White discharge per-vaginum Pain in the lower abdomen Intermenstrual bleeding Post-menopausal bleeding Dyspareunia Menstrual abnormalities

Exclusion criteria

Exclusion criteria: Women below 20 years of age Women who are pregnant Women who use local douche Women not willing to give consent for pap smear/ HPV testing

Design outcomes

Primary

MeasureTime frame
This study could reveal the effectiveness of urine samples as a non-invasive alternative to cervical swabs for detecting HPV and its genotypes.Timepoint: 1 year

Secondary

MeasureTime frame
This Study can help in early identification of high-risk Oncogenic cases.Timepoint: 1 year;Thia study can evaluate the accuracy & effectiveness of Pap smears in detecting early-stage cervical cancer. This can help improve diagnostic practices & guidelines.Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Sribal S

Sri Ramachandra Medical College and Research Institute

dr.sribal@sriramachandra.edu.in9884118630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026